Boardroom Alpha
Boardroom Alpha
CMCO · Current Report (Form 8-K) · Filed September 22, 2026

Columbus Mckinnon Corp — Current Report (Form 8-K)

Form
8-K
Filed
September 22, 2026
Period
Sep 21, 2026
Ticker
CMCO
Accession
0001193125-26-397298
Boardroom Alpha · Filing insights

Columbus McKinnon refinances Term Loan B into Tranche B with lower margins; margins reduced; JP Morgan SE appointed administrative agent.

About Columbus Mckinnon Corp
Market cap
$455M
1Y TSR
+19.1%
3Y TSR
−20.3%
Board grade
C+
Sector
Industrials
CEO
David J Wilson
Last annual meeting: Aug 14, 2026 · View full Columbus Mckinnon Corp profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 21, 2026

 

 

COLUMBUS McKINNON CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York   001-34362   16-0547600

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

13320 Ballantyne Corporate Place, Suite D    Charlotte      NC    28277
(Address of principal executive offices)    (Zip Code)

Registrant’s telephone number, including area code: (716) 689-5400

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.01 par value per share   CMCO   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into a Material Definitive Agreement.

On September 21, 2026, Columbus McKinnon Corporation (the “Company”), Columbus McKinnon EMEA GmbH (the “German Borrower”) and certain subsidiary guarantors of the Company entered into that certain First Amendment (the “First Amendment”) to its Credit Agreement, dated as of February 3, 2026 (the “Existing Credit Agreement” and the credit facilities thereunder, the “Senior Credit Facilities”), by and among the Company, the German Borrower, certain subsidiary guarantors of the Company, the lenders from time to time thereto, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.

Pursuant to the First Amendment, (a) the initial term loans outstanding under the Existing Credit Agreement (the “Term Loan B Facility”) as of the First Amendment Effective Date (as defined in the First Amendment) were refinanced with Tranche B Term Loans (as defined in the First Amendment) in an aggregate principal amount of $1,452.9 million at an applicable interest rate margin that was reduced by 0.50% per annum and (b) the applicable interest rate margin on the existing revolving credit facility under the Existing Credit Agreement (the “Revolving Facility”) was also similarly reduced by 0.50% per annum. The existing term lenders under the Term Loan B Facility were offered the option to participate in the refinancing either through a cashless conversion of their existing term loans into a like principal amount of Tranche B Term Loans or, alternatively, to have their existing term loans prepaid from the proceeds of the Tranche B Term Loans funded by new and existing term lenders under the Term Loan B Facility. Following the effectiveness of the First Amendment, the Senior Credit Facilities bear interest at rates determined on the basis of either a term SOFR or a base rate plus an applicable margin. In the case of term SOFR loans under the Term Loan B Facility, such margin is 3.00%, and in the case of dollar denominated term SOFR loans under the Revolving Facility, such margin ranges from 1.75% to 2.75% based upon the Company’s Consolidated Total Leverage Ratio (as defined in the Existing Credit Agreement). The First Amendment also added J.P. Morgan SE as administrative agent with respect to the German Borrower and any other EEA Agented Borrower (as defined in the First Amendment).

No other material changes were made to the terms of the Term Loan B Facility, the Revolving Facility or the Existing Credit Agreement.

The foregoing description of the First Amendment does not purport to be complete and is qualified in its entirety by the First Amendment, a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

 

Item 7.01

Regulation FD Disclosure.

On September 22, 2026, the Company issued a press release announcing closing of the Term Loan B Facility and the Revolving Facility repricing transaction described above, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Item 7.01 and the exhibit attached to this Current Report on Form 8-K as Exhibit 99.1 are being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COLUMBUS McKINNON CORPORATION
By:  

/s/ John R. Linker

Name:   John R. Linker
Title:   Executive Vice President and Chief Financial Officer

Dated: September 22, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Columbus Mckinnon Corp (CMCO)

Reference

Frequently asked questions

When did Columbus Mckinnon Corp file this 8-K?
Columbus Mckinnon Corp (CMCO) filed this Current Report (Form 8-K) with the SEC on September 22, 2026. The accession number assigned by EDGAR is 0001193125-26-397298.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Columbus McKinnon refinances Term Loan B into Tranche B with lower margins; margins reduced; JP Morgan SE appointed administrative agent. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Columbus Mckinnon Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Columbus Mckinnon Corp has filed under CIK 1005229, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer